Science & Enterprise subscription

Follow us on Twitter

  • University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promisi… https://t.co/teoJmmS7Hi
    about 4 hours ago
  • New post on Science and Enterprise: Health Research Commercialization Company Launched https://t.co/IOKEXZQSg2 #Science #Business
    about 4 hours ago
  • A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its s… https://t.co/pluS8d03pW
    about 10 hours ago
  • New post on Science and Enterprise: Antibody Drug Biotech Raises $105M in Venture Funds https://t.co/9YmpThcKVv #Science #Business
    about 10 hours ago
  • https://t.co/PNy7n5Obv1
    about 14 hours ago

Please share Science & Enterprise

Antibody Drug Biotech Raises $105M in Venture Funds

Human B-cell

A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds

Merck Inks Three Covid-19 Vaccine, Therapy Deals

SARS-Cov-2 virus

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

Covid-19 Therapies Designed with Virtual Reality, A.I.

SARS-CoV-2 protease

Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed. . . . → Read More: Covid-19 Therapies Designed with Virtual Reality, A.I.

GSK, Biotech Partner on Crispr Covid-19 Test

Crispr genome edits illustration

A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline. . . . → Read More: GSK, Biotech Partner on Crispr Covid-19 Test

Covid-19 Vaccine Produces Antibodies in Preclinical Test

Global Covid-19

Tests with lab animals show a Covid-19 vaccine now in clinical trials produces neutralizing antibodies to prevent coronavirus infections. . . . → Read More: Covid-19 Vaccine Produces Antibodies in Preclinical Test

Venture Producing Covid-19 Antibody Test Kits

SARS-Cov-2 virus

A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies. . . . → Read More: Venture Producing Covid-19 Antibody Test Kits

FDA Analyzing Real-World Evidence on Covid-19

Network pointer

The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic. . . . → Read More: FDA Analyzing Real-World Evidence on Covid-19

Antibody Neutralizes Covid-19, SARS Viruses

David Veesler

An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections. . . . → Read More: Antibody Neutralizes Covid-19, SARS Viruses

Covid-19 Vaccine Generates Immune Response

Syrine ingloved hand

First results from a clinical trial testing a vaccine to protect against Covid-19 infections show the vaccine produces an immune response in healthy participants. . . . → Read More: Covid-19 Vaccine Generates Immune Response

FDA Stops Home Covid-19 Diagnostic Test

Covid-19 illustration

The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals. . . . → Read More: FDA Stops Home Covid-19 Diagnostic Test